Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy

Epigenetics

Volumn 9, Issue 7, 2014, Pages 964-972

  Non, Amy L ^a   Binder, Alexandra M ^a   Kubzansky, Laura D ^a   Michels, Karin B ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Antidepressants; Anxiety; Depression; DNA methylation; HumanMethylation450 BeadChip; Prenatal exposures; SSRI

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; FK 506 BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; ANTIDEPRESSANT AGENT;

ANXIETY; ARTICLE; CELL DIVISION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPIGENETICS; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE ONTOLOGY; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; MALE; NEWBORN; PERINATAL DEVELOPMENT; PREGNANCY; PRENATAL EXPOSURE; PUERPERAL DEPRESSION; PYROSEQUENCING; QUESTIONNAIRE; RNA TRANSLATION; UMBILICAL CORD BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; COMPLICATION; CYTOLOGY; DEPRESSION; ETIOLOGY; FETUS BLOOD; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; METABOLISM; PREGNANCY COMPLICATIONS; PROTEIN SYNTHESIS;

ANTIDEPRESSIVE AGENTS; ANXIETY; CASE-CONTROL STUDIES; CELL DIVISION; COHORT STUDIES; CPG ISLANDS; DEPRESSION; DNA METHYLATION; FEMALE; FETAL BLOOD; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENOME, HUMAN; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEIN BIOSYNTHESIS; SEROTONIN UPTAKE INHIBITORS;

EID: 84903728455     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.28853     Document Type: Article

References (49)

1. Bennett HA, Einarson A, Taddio A, Koren G, Einarson TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004; 103:698-709; PMID: 15051562; http://dx.doi.org/10.1097/01.AOG.0000116689.75396.5f
2. Ross LE, McLean LM. Anxiety disorders during pregnancy and the postpartum period: A systematic review. J Clin Psychiatry 2006; 67:1285-1298; PMID:16965210; http://dx.doi.org/10.4088/JCP.v67n0818
3. Grigoriadis S, VonderPorten EH, Mamisashvili L, Tomlinson G, Dennis CL, Koren G, Steiner M, Mousmanis P, Cheung A, Radford K, et al. The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis. J Clin Psychiatry 2013; 74:e321-e341; PMID:23656857; http://dx.doi.org/10.4088/JCP.12r07968
4. Hoffman S, Hatch MC. Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women. Health Psychol 2000; 19:535-543; PMID:11129356; http://dx.doi.org/10.1037/0278-6133.19.6.535
5. Field T, Diego M, Hernandez-Reif M, Schanberg S, Kuhn C, Yando R, Bendell D. Pregnancy anxiety and comorbid depression and anger: effects on the fetus and neonate. Depress Anxiety 2003; 17:140-151; PMID:12768648; http://dx.doi.org/10.1002/da.10071
6. Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry 2012; 169:1165-1174; PMID:23128923; http://dx.doi.org/10.1176/appi.ajp.2012.11111721
7. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, Rolnick SJ, Roblin D, Smith DH, Willy ME, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008; 198:e1-e5; PMID:17905176; http://dx.doi.org/10.1016/j.ajog.2007.07.036
8. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor anti-depressants: population-based study. Br J Psychiatry 2008; 192:338-343; PMID:18450656; http://dx.doi.org/10.1192/bjp.bp.107.037101
9. Oberlander TF, Warburton W, Misri S, Aghajanian J, Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 2006; 63:898-906; PMID:16894066; http://dx.doi.org/10.1001/archpsyc.63.8.898
10. Ross LE, Grigoriadis S, Mamisashvili L, Vonderporten EH, Roerecke M, Rehm J, Dennis CL, Koren G, Steiner M, Mousmanis P, et al. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 2013; 70:436-443; PMID:23446732; http://dx.doi.org/10.1001/jamapsychiatry.2013.684
11. Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, Wisner KL. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 2005; 293:2372-2383; PMID:15900008; http://dx.doi.org/10.1001/jama.293.19.2372
12. Lattimore KA, Donn SM, Kaciroti N, Kemper AR, Neal CR Jr., Vazquez DM. Selective serotonin reup-take inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis. J Perinatol 2005; 25:595-604; PMID:16015372; http://dx.doi.org/10.1038/sj.jp.7211352
13. Kim J, Riggs K W, Misri S, Kent N, Oberlander TF, Grunau RE, Fitzgerald C, Rurak DW. Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding. Br J Clin Pharmacol 2006; 61: 155-163; PMID:16433870; http://dx.doi.org/10.1111/j.1365-2125.2005.02538.x.
14. Foley DL, Craig JM, Morley R, Olsson CA, Dwyer T, Smith K, Saffery R. Prospects for epigenetic epidemiology. Am J Epidemiol 2009; 169:389-400; PMID:19139055; http://dx.doi.org/10.1093/aje/kwn380
15. Jensen Peña C, Monk C, Champagne FA. Epigenetic effects of prenatal stress on 11β-hydroxysteroid dehydrogenase-2 in the placenta and fetal brain. PLoS One 2012; 7:e39791; PMID:22761903; http://dx.doi.org/10.1371/journal.pone.0039791
16. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC, Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7:847-854; PMID:15220929; http://dx.doi.org/10.1038/nn1276
17. Bjartmar L, Johansson IM, Marcusson J, Ross SB, Seckl JR, Olsson T. Selective effects on NGFI-A, MR, GR and NGFI-B hippocampal mRNA expression after chronic treatment with different subclasses of antidepressants in the rat. Psychopharmacology (Berl) 2000; 151:7-12; PMID:10958110; http://dx.doi.org/10.1007/s002130000468
18. Yau JL, Hibberd C, Noble J, Seckl JR. The effect of chronic fluoxetine treatment on brain corticoste-roid receptor mRNA expression and spatial memory in young and aged rats. Brain Res Mol Brain Res 2002; 106:117-123; PMID:12393271; http://dx.doi. org/10.1016/S0169-328X(02)00418-7
19. Cassel S, Carouge D, Gensburger C, Anglard P, Burgun C, Dietrich JB, Aunis D, Zwiller J. Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 20 06; 70: 487-492; PMID:16670375; http://dx.doi.org/10.1124/mol.106.022301
20. Philibert RA, Sandhu H, Hollenbeck N, Gunter T, Adams W, Madan A. The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies. Am J Med Genet B Neuropsychiatr Genet 2008; 147B:543-549; PMID:17987668; http://dx.doi.org/10.1002/ajmg.b.30657
21. Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N, Inoue T, Kusumi I, Koyama T, Tsuchiyama K, et al. DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. PLoS One 2011; 6:e23881; PMID:21912609; http://dx.doi.org/10.1371/journal.pone.0023881
22. Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM. Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008; 3:97-106; PMID: 18536531; http://dx.doi.org/10.4161/epi.3.2.6034
23. Devlin AM, Brain U, Austin J, Oberlander TF. Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS One 2010; 5:e12201; PMID:20808944; http://dx.doi.org/10.1371/journal.pone. 0012201
24. Schroeder JW, Smith AK, Brennan PA, Conneely KN, Kilaru V, Knight BT, Newport DJ, Cubells JF, Stowe ZN. DNA methylation in neonates born to women receiving psychiatric care. Epigenetics 2012; 7:409-414; PMID:22419064; http://dx.doi.org/10.4161/epi. 19551
25. Claus R, Lucas DM, Stilgenbauer S, Ruppert AS, Yu L, Zucknick M, Mertens D, Bühler A, Oakes CC, Larson RA, et al. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. J Clin Oncol 2012; 30:2483-2491; PMID:22564988; http://dx.doi.org/10.1200/JCO.2011.39.3090
26. Sohn BH, Park IY, Lee JJ, Yang SJ, Jang YJ, Park KC, Kim DJ, Lee DC, Sohn HA, Kim TW, et al. Functional switching of TGF-J31 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter. Gastroenterology 2010; 138:1898-1908, e12; PMID:20038433; http://dx.doi.org/10.1053/j.gastro.2009.12.044
27. Wertheim-Tysarowska K, Sobczyńska-Tomaszewska A, Kowalewski C, Skroriski M, Swińćkowski G, Kutkowska-Kaźmierczak A, Woźniak K, Bal J. The COL7A1 mutation database. Hum Mutat 2012; 33:327-331; PMID:22058051; http://dx.doi.org/10.1002/humu.21651
28. Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006; 31:89-97; PMID:16403636; http://dx.doi.org/10.1016/j.tibs.20 05.12.008
29. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012; 13:484-492; PMID:22641018; http://dx.doi.org/10.1038/nrg3230
30. Essex MJ, Boyce WT, Hertzman C, Lam LL, Armstrong JM, Neumann SM, Kobor MS. Epigenetic vestiges of early developmental adversity: childhood stress exposure and DNA methylation in adolescence. Child Dev 2013; 84:58-75; PMID:21883162; http://dx.doi.org/10.1111/j.14 67-8624.2011.01641.x
31. Borghol N, Suderman M, McArdle W, Racine A, Hallett M, Pembrey M, Hertzman C, Power C, Szyf M. Associations with early-life socio-economic position in adult DNA methylation. Int J Epidemiol 2012; 41: 62-74; PMID:22422449; http://dx.doi.org/10.1093/ije/dyr147
32. Conradt E, Lester BM, Appleton AA, Armstrong DA, Marsit CJ. The roles of DNA methylation of NR3C1 and 11β-HSD2 and exposure to maternal mood disorder in utero on newborn neurobehavior. Epigenetics 2013; 8:1321-1329; PMID:24135662; http://dx.doi.org/10.4161/epi.26634
33. Liu Y, Murphy SK, Murtha AP, Fuemmeler BF, Schildkraut J, Huang Z, Overcash F, Kurtzberg J, Jirtle R, Iversen ES, et al. Depression in pregnancy, infant birth weight and DNA methylation of imprint regulatory elements. Epigenetics 2012; 7:735-746; PMID:22677950; http://dx.doi.org/10.4161/epi.20734
34. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCSR). JAMA 2003; 289:3095-3105; PMID: 12813115; http://dx.doi.org/10.1001/jama.289.23.3095
35. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, Coarfa C, Harris RA, Milosavljevic A, Troakes C, et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012; 13:R43; PMID:22703893; http://dx.doi.org/10.1186/gb-2012-13-6-r43
36. Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am J Psychiatry 2003; 160:993-996; PMID:12727706; http://dx.doi.org/10.1176/appi.ajp.160.5.993
37. Capello CF, Bourke CH, Ritchie JC, Stowe ZN, Newport DJ, Nemeroff A, Owens MJ. Serotonin transporter occupancy in rats exposed to serotonin reuptake inhibitors in utero or via breast milk. J Pharmacol Exp Ther 2011; 339:275-285; PMID:21775476; http://dx.doi.org/10.1124/jpet.111.183855
38. Michels KB, Harris HR, Barault L. Birthweight, maternal weight trajectories and global DNA methylation of LINE-1 repetitive elements. PLoS One 2011; 6:e25254; PMID:21980406; http://dx.doi.org/10.1371/journal.pone.0025254
39. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, Gunderson KL. Genome-wide DNA methylation profiling using Infinium® assay. Epigenomics 2009; 1:177-200; PMID:22122642; http://dx.doi.org/10.2217/epi.09.14
40. Ban L, Gibson JE, West J, Fiaschi L, Oates MR, Tata LJ. Impact of socioeconomic deprivation on maternal perinatal mental illnesses presenting to UK general practice. Br J Gen Pract 2012; 62:e671-e678; PMID:23265226; http://dx.doi.org/10.3399/bjgp12X656801
41. Bodnar LM, Wisner KL, Moses-Kolko E, Sit DK, Hanusa BH. Prepregnancy body mass index, gestational weight gain, and the likelihood of major depressive disorder during pregnancy. J Clin Psychiatry 2009; 70:1290-1296; PMI D:19607761; http://dx.doi.org/10.4088/JCP.08m04651
42. Gemma C, Sookoian S, Alvariñas J, García SI, Quintana L, Kanevsky D, González CD, Pirola CJ. Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns. Obesity (Silver Spring) 2009; 17:1032-1039; PMID:19148128; http://dx.doi.org/10.1038/oby.2008.605
43. Adkins RM, Thomas F, Tylavsky FA, Krushkal J. Parental ages and levels of DNA methylation in the newborn are correlated. BMC Med Genet 2011; 12: 47; PMID: 21453505; http://dx.doi. org/10.1186/1471-2350-12-47
44. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonté B, Szyf M, Turecki G, Meaney MJ. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009; 12:342-348; PM I D:192 3 4 457; http://dx.doi.org/10.1038/nn.2270
45. Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, Pace TW, Mercer KB, Mayberg HS, Bradley B, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 2013; 16:33-41; PMID: 23201972; http://dx.doi.org/10.1038/nn.3275
46. Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V, Sacchetti S, Lembo F, Angiolillo A, Jovanovic N, et al. Increased BDNF promoter meth-ylation in the Wernicke area of suicide subjects. Arch Gen Psychiatry 2010; 67:258-267; PMID:20194826; http://dx.doi.org/10.1001/archgenpsychiatry.2010.9
47. Wang D, Szyf M, Benkelfat C, Provençal N, Turecki G, Caramaschi D, Côté SM, Vitaro F, Tremblay RE, Booij L. Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS One 2012; 7:e39501; PMID:22745770; http://dx.doi.org/10.1371/journal.pone.0039501
48. Bradley RG, Binder EB, Epstein MP, Tang Y, Nair HP, Liu W, Gillespie CF, Berg T, Evces M, Newport DJ, et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry 2008; 65:190-200; PMID:18250257; http://dx.doi.org/10.1001/archgenpsychiatry.2007.26
49. Wolf JM, Rohleder N, Bierhaus A, Nawroth PP, Kirschbaum C. Determinants of the NF-kappaB response to acute psychosocial stress in humans. Brain Behav Immun 2009; 23:742-749; PMID:18848620; http://dx.doi.org/10.1016/j.bbi.2008.09.009